Abbott Laboratories (NYSE:ABT) Stake Lessened by Assenagon Asset Management S.A.
Assenagon Asset Management S.A. lowered its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 21.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 418,751 shares of the healthcare product maker’s stock after selling 117,176 shares during the quarter. Assenagon Asset Management […]